Frovatriptan succinate
- Level
- Commodity
- Parent
- 51142400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51142429This classification denotes a serotonin agonist with the molecular formula C14H17N3O.C4H6O4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D28J6W18HY, chemically known as 1h-carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (r)-, butanedioate (1:1) but more generally known as frovatriptan succinate, which bears US NIH Compound Identifier 152944. European Medicines Agency schedules Frovatriptan succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22174. Most nations, for tariff and trade purposes, schedule frovatriptan succinate under HS 29339990. As of Q4 2014, FROVATRIPTAN SUCCINATE remains US FDA's Preferred Term for this commodity. Frovatriptan succinate bears US NLM identifiers UMLS ID C1099777 and NCI Concept Code C47544. SMILES: CN[C@@H]1CCC2C(C3CC(CCC3[NH]2)C(=O)N)C1.C(CC(=O)O)C(=O)O.O.
Same parent
Under 51142400 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.